Emergence of New ALK Mutations at Relapse of Neuroblastoma.

Research output: Contribution to journalArticle

Abstract

In neuroblastoma, the ALK receptor tyrosine kinase is activated by point mutations. We investigated the potential role of ALK mutations in neuroblastoma clonal evolution.

Details

Authors
  • Gudrun Schleiermacher
  • Niloufar Javanmardi
  • Virginie Bernard
  • Quentin Leroy
  • Julie Cappo
  • Thomas Rio Frio
  • Gaelle Pierron
  • Eve Lapouble
  • Valérie Combaret
  • Frank Speleman
  • Bram de Wilde
  • Anna Djos
  • Fredrik Hedborg
  • Catarina Träger
  • Britt-Marie Holmqvist
  • Jonas Abrahamsson
  • Michel Peuchmaur
  • Jean Michon
  • Isabelle Janoueix-Lerosey
  • Per Kogner
  • Olivier Delattre
  • Tommy Martinsson
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)2727
JournalJournal of Clinical Oncology
Volume32
Issue number25
Publication statusPublished - 2014
Publication categoryResearch
Peer-reviewedYes